🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/2006 | 38,59 | 38,74 | 36,64 | 37,09 | -4,25% | 5,43% | 411.357 |
| 11/09/2006 | 39,56 | 39,56 | 37,84 | 38,74 | -1,99% | 4,35% | 459.901 |
| 08/09/2006 | 39,79 | 40,20 | 38,93 | 39,53 | +6,13% | 3,20% | 1.398.805 |
| 07/09/2006 | 36,68 | 37,88 | 34,62 | 37,24 | +0,81% | 8,88% | 915.126 |
| 06/09/2006 | 37,06 | 37,47 | 36,01 | 36,94 | -0,10% | 3,94% | 96.714 |
| 05/09/2006 | 37,95 | 37,95 | 36,79 | 36,98 | -2,56% | 3,06% | 178.147 |
| 01/09/2006 | 37,95 | 38,37 | 37,47 | 37,95 | +0,00% | 2,37% | 63.906 |
| 31/08/2006 | 36,87 | 38,18 | 36,53 | 37,95 | +2,94% | 4,47% | 155.037 |
| 30/08/2006 | 36,27 | 37,17 | 35,93 | 36,87 | +1,34% | 3,41% | 171.200 |
| 29/08/2006 | 35,78 | 36,61 | 35,18 | 36,38 | +1,46% | 3,98% | 32.487 |
| 28/08/2006 | 35,82 | 36,64 | 35,15 | 35,86 | -0,21% | 4,18% | 148.358 |
| 25/08/2006 | 35,78 | 36,72 | 35,63 | 35,93 | +0,00% | 3,03% | 43.441 |
| 24/08/2006 | 35,86 | 36,31 | 35,75 | 35,93 | +0,31% | 1,57% | 38.525 |
| 23/08/2006 | 36,34 | 36,68 | 35,48 | 35,82 | -2,05% | 3,30% | 62.063 |
| 22/08/2006 | 36,87 | 37,09 | 35,86 | 36,57 | -0,51% | 3,35% | 58.242 |
| 21/08/2006 | 35,75 | 37,13 | 35,56 | 36,76 | +2,29% | 4,40% | 69.971 |
| 18/08/2006 | 35,11 | 35,93 | 34,55 | 35,93 | +2,13% | 3,94% | 45.953 |
| 17/08/2006 | 34,66 | 35,48 | 34,62 | 35,18 | +1,08% | 2,48% | 47.823 |
| 16/08/2006 | 34,85 | 35,03 | 33,69 | 34,81 | +1,09% | 3,87% | 85.948 |
| 15/08/2006 | 33,13 | 34,62 | 33,13 | 34,44 | +3,95% | 4,52% | 88.753 |
| 14/08/2006 | 32,00 | 33,61 | 32,00 | 33,13 | +1,03% | 5,03% | 37.056 |
| 11/08/2006 | 31,10 | 33,61 | 31,10 | 32,79 | +4,04% | 8,06% | 90.489 |
| 10/08/2006 | 31,97 | 33,61 | 31,14 | 31,52 | -2,77% | 7,73% | 96.714 |
| 09/08/2006 | 33,46 | 33,61 | 32,34 | 32,41 | -1,59% | 3,80% | 32.541 |
| 08/08/2006 | 34,25 | 34,55 | 32,94 | 32,94 | -3,30% | 4,70% | 31.045 |
| 07/08/2006 | 33,31 | 34,70 | 33,31 | 34,06 | +1,22% | 4,16% | 35.800 |
| 04/08/2006 | 33,95 | 34,96 | 33,16 | 33,65 | -2,28% | 5,29% | 53.781 |
| 03/08/2006 | 34,25 | 34,88 | 32,94 | 34,44 | +0,44% | 5,68% | 185.013 |
| 02/08/2006 | 33,50 | 34,77 | 33,50 | 34,29 | +1,89% | 3,80% | 48.731 |
| 01/08/2006 | 36,31 | 36,46 | 33,35 | 33,65 | -2,60% | 8,56% | 249.454 |